1. Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine (Phila Pa 1976) 1993 18:1425–1432. PMID:
8235812.
2. Olmarker K, Larsson K. Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine (Phila Pa 1976) 1998 23:2538–2544. PMID:
9854752.
3. Toyone T, Takahashi K, Kitahara H, Yamagata M, Murakami M, Moriya H. Visualisation of symptomatic nerve roots. Prospective study of contrast-enhanced MRI in patients with lumbar disc herniation. J Bone Joint Surg Br 1993 75:529–533. PMID:
8331104.
4. Olmarker K, Storkson R, Berge OG. Pathogenesis of sciatic pain: a study of spontaneous behavior in rats exposed to experimental disc herniation. Spine (Phila Pa 1976) 2002 27:1312–1317. PMID:
12065980.
5. Olmarker K, Nutu M, Storkson R. Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition. Spine (Phila Pa 1976) 2003 28:1635–1641. PMID:
12897484.
6. Korhonen T, Karppinen J, Malmivaara A, et al. Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up. Spine (Phila Pa 1976) 2004 29:2115–2119. PMID:
15454701.
7. Korhonen T, Karppinen J, Paimela L, et al. The treatment of disc herniation-induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study. Spine (Phila Pa 1976) 2005 30:2724–2728. PMID:
16371894.
8. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996 87:13–20. PMID:
8858144.
9. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997 336:1066–1071. PMID:
9091804.
10. Chan CF, Sun WZ, Lin JK, Lin-Shiau SY. Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia. Eur J Pharmacol 2000 402:61–68. PMID:
10940358.
11. Ma W, Bisby MA. Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res 1998 797:243–254. PMID:
9666140.
12. Novack DV, Teitelbaum SL. The osteoclast: friend or foe? Annu Rev Pathol 2008 3:457–484. PMID:
18039135.
13. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 2007 22:724–729. PMID:
17295604.
14. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003 111:1221–1230. PMID:
12697741.
15. Feng X. Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene 2005 350:1–13. PMID:
15777737.
16. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000 289:1504–1508. PMID:
10968780.
17. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008 473:139–146. PMID:
18395508.
18. Takasaki I, Andoh T, Shiraki K, Kuraishi Y. Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain 2000 86:95–101. PMID:
10779666.
19. Ohtori S, Takahashi K, Aoki Y, et al. Spinal neural cyclooxygenase-2 mediates pain caused in a rat model of lumbar disk herniation. J Pain 2004 5:385–391. PMID:
15501196.
20. Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K. Distribution and appearance of tumor necrosis factor-alpha in the dorsal root ganglion exposed to experimental disc herniation in rats. Spine (Phila Pa 1976) 2004 29:2235–2241. PMID:
15480134.
21. Obata K, Tsujino H, Yamanaka H, et al. Expression of neurotrophic factors in the dorsal root ganglion in a rat model of lumbar disc herniation. Pain 2002 99:121–132. PMID:
12237190.
22. Onda A, Murata Y, Rydevik B, Larsson K, Kikuchi S, Olmarker K. Infliximab attenuates immunoreactivity of brain-derived neurotrophic factor in a rat model of herniated nucleus pulposus. Spine (Phila Pa 1976) 2004 29:1857–1861. PMID:
15534405.
23. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine (Phila Pa 1976) 2001 26:863–869. PMID:
11317106.
24. Ohtori S, Miyagi M, Eguchi Y, et al. Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study. Spine (Phila Pa 1976) 2012 37:439–444. PMID:
22020607.
25. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997 3:894–899. PMID:
9256281.
26. Sakurai H, Shigemori N, Hisada Y, Ishizuka T, Kawashima K, Sugita T. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. Biochim Biophys Acta 1997 1362:252–262. PMID:
9540856.
27. Inoue G, Ochiai N, Ohtori S, et al. Injection of nuclear factor-kappa B decoy into the sciatic nerve suppresses mechanical allodynia and thermal hyperalgesia in a rat inflammatory pain model. Spine (Phila Pa 1976) 2006 31:2904–2908. PMID:
17139220.
28. Suzuki M, Inoue G, Gemba T, et al. Nuclear factor-kappa B decoy suppresses nerve injury and improves mechanical allodynia and thermal hyperalgesia in a rat lumbar disc herniation model. Eur Spine J 2009 18:1001–1007. PMID:
19308465.
29. Smith HS, Barkin RL. Painful boney metastases. Am J Ther 2014 21:106–130. PMID:
23344095.
30. Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010 11:275–280. PMID:
20149736.
31. Moen MD, Keam SJ. Denosumab: a review of its use in the treatment of postmenopausal osteoporosis. Drugs Aging 2011 28:63–82. PMID:
21174488.
32. Sakuma T, Kamoda H, Miyagi M, et al. Comparison of CatWalk analysis and von Frey testing for pain assessment in a rat model of nerve crush plus inflammation. Spine (Phila Pa 1976) 2013 38:E919–E924. PMID:
23615382.
33. Norimoto M, Ohtori S, Yamashita M, et al. Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats. Spine (Phila Pa 1976) 2008 33:2403–2408. PMID:
18824950.
34. Yamashita M, Ohtori S, Koshi T, et al. Tumor necrosis factor-alpha in the nucleus pulposus mediates radicular pain, but not increase of inflammatory peptide, associated with nerve damage in mice. Spine (Phila Pa 1976) 2008 33:1836–1842. PMID:
18670336.